| 注册
首页|期刊导航|山东医药|维持性血液透析患者贫血治疗效果的影响因素分析

维持性血液透析患者贫血治疗效果的影响因素分析

王梦平 曾炎 王明初 温向琼 吴蔚华 甘林望 秦露丹 丁静雅 刘建

山东医药2017,Vol.57Issue(47):56-59,4.
山东医药2017,Vol.57Issue(47):56-59,4.DOI:10.3969/j.issn.1002-266X.2017.47.017

维持性血液透析患者贫血治疗效果的影响因素分析

Influencing factors of anemia treatment in maintenance hemodialysis patients

王梦平 1曾炎 2王明初 3温向琼 1吴蔚华 1甘林望 1秦露丹 1丁静雅 1刘建1

作者信息

  • 1. 西南医科大学附属医院,四川泸州646000
  • 2. 西南医科大学附属中医医院
  • 3. 泸州市人民医院
  • 折叠

摘要

Abstract

Objective To analyze the influencing factors of anemia treatment in maintenance hemodialysis (MHD) patients.Methods Totally 337 cases of patients with end-stage renal disease were divided into the substandard group of 179 cases (Hb < 110 g/L) and standard group of 158 cases (Hb ≥ 110 g/L) according to anemia guidelines.Single factor analysis was used to compare the clinical data of two groups,and the Multi-factor Logistic regression analysis was used to compare the influencing factors for anemia treatment.Results In the standard group,patients with diabetes accounted for 18.4%,with hemoperfusion (HP) frequency more than 2 h/month accounted for 50.6%,patients who took angiotensin converting enzyme inhibitor (ACEI)/angiotensin Ⅱ receptor antagonist (ARB) accounted for 35.4%,the high sensitive C reactive protein (hs-CRP) was (2.21 ± 3.12) mg/L,the serum phosphorus before hemodialysis was (1.93 ±0.65) mmol/L,and the serum albumin before hemodialysis was (39.76 ± 3.11) g/L,patients with transferrin saturation (TSAT) >0.2 accounted for 91.8%,and the single chamber urea clearance index (spKt/V) was i.38 ±0.27;in the substandard group,the above indexes were separately 27.9%,35.2%,53.1%,(3.92 ± 4.42) mg/L,(1.77 ± 0.58) mmol/L,(38.38 ±3.38) g/L,82.7%,and 1.30 ±0.29;the differences were statistically significant between these two groups (all P <0.05).The SpKt/V,frequency of HP,taking ACEI/ARB,TSAT,hs-CRP,and serum albumin before HD were related to anemia treatment,during which,spKt/V,frequency of HP > 2 h/month,TSAT > 0.2,serum albumin before HD were the protective factors for anemia treatment,and taking ACEI/ARB and hs-CRP were risk factors for anemia treatment.Conclusions Standard-reaching rate of anemia treatment in MHD patients is low.Further more,inadequate dialysis,inadequate blood perfusion,taking ACEI/ARB,iron deficiency,inflammation,and malnutrition may be the influencing factors for anemia treatment.

关键词

血液透析/贫血/单室尿素清除指数/血液灌流频率/血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂/转铁蛋白饱和度/超敏C反应蛋白/血液透析前血白蛋白

Key words

hemodialysis/anemia/single chamber urea clearance index/blood perfusion frequency/angiotensin converting enzyme inhibitor/angiotensin Ⅱ receptor antagonist/transferrin saturation/hypersensitive C reactive protein/serum albumin before hemodialysis

分类

医药卫生

引用本文复制引用

王梦平,曾炎,王明初,温向琼,吴蔚华,甘林望,秦露丹,丁静雅,刘建..维持性血液透析患者贫血治疗效果的影响因素分析[J].山东医药,2017,57(47):56-59,4.

基金项目

四川省教育厅科研计划(14ZA0136). (14ZA0136)

山东医药

OACSTPCD

1002-266X

访问量0
|
下载量0
段落导航相关论文